Smart scans and DNA tests could revolutionize liver cancer care
NCT ID NCT04597710
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether combining detailed MRI scans with whole genome sequencing can help doctors choose the best treatment for people with liver cancer. Researchers studied 200 adults who were scheduled for liver surgery. The goal was to see if these advanced tests provide useful information that could change a patient's treatment plan, potentially leading to better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Basingstoke and North Hampshire Hospital
Basingstoke, Hampshire, RG249NA, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can targeted liver chemo turn inoperable tumors into operable ones?
- Could a vaccine help fight Hard-to-Treat cancers?
- A new test could reveal how radiation affects the liver
- Ancient wisdom meets modern oncology: can TCM body types forecast treatment side effects?
- Can an epidural pump beat IV painkillers after liver surgery?
- Could a two-vein embolization trick turn inoperable liver tumors into operable ones?